- Home
- XERS vs NBR Comparison
XERS vs NBR Comparison
Compare XERS & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | NBR |
|---|---|---|
| Founded | 2005 | 1952 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 965.6M | 930.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | XERS | NBR |
|---|---|---|
| Price | $5.47 | $75.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $10.43 | ★ $64.57 |
| AVG Volume (30 Days) | ★ 2.1M | 405.6K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $28.65 | $3.59 |
| Revenue Next Year | $18.33 | $4.88 |
| P/E Ratio | ★ N/A | $4.33 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $3.81 | $23.27 |
| 52 Week High | $10.08 | $83.01 |
Technical Indicators
Market Signals| Indicator | XERS | NBR |
|---|---|---|
| Relative Strength Index (RSI) | 26.31 | 53.59 |
| Support Level | $4.30 | $74.00 |
| Resistance Level | $5.49 | $82.30 |
| Average True Range (ATR) | 0.34 | 3.75 |
| MACD | -0.06 | -0.68 |
| Stochastic Oscillator | 3.62 | 25.51 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.